Scientists have discovered that an artificial intelligence program, coupled with the chemical analysis of blood samples, could speed up brain tumor diagnosis.
Browsing: blood test
A blood test that measures the amount of cfDNA has been indicated to be correlated with how patients will progress following a glioblastoma diagnosis.
A recently published study has determined that GFAP and UCH-L1 may be used as blood biomarkers to detect concussion and subconcussive injuries.
A blood test for glioblastoma may be on the horizons, as researchers identify novel biomarkers that could be used for diagnosis.
In this video, we spoke with Henrik Zetterberg to find out how challenges with replication, reproducibility and specificity could be addressed in the field.
A blood test to diagnose individuals at risk of developing Alzheimer’s disease before symptoms arise may be closer to reality, as researchers report a 94% accuracy in recent findings.
Studies presented at AAIC 2019 have revealed the significant advances being made in the global search for blood-based biomarkers for dementia.
A novel study has identified the inflammatory markers IL-1 and IL-6 as potential biomarkers for diagnosis, prognosis and possible treatment targets for concussion.
A promising new study could provide an early warning system to enable people with epilepsy to know when they are at risk of having a seizure.
A simple blood test could detect the earliest changes caused by Huntington’s disease, even before scans pick up any signs in the brain.